These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6336258)

  • 1. Considerations in the design of a peptide antigen specific for T cells.
    Heber-Katz E; Hollosi M; Hudecz F; Fasman G; Dietzschold B
    Ann Sclavo Collana Monogr; 1984; 1(2):119-28. PubMed ID: 6336258
    [No Abstract]   [Full Text] [Related]  

  • 2. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The T-cell repertoire for antigen and MHC.
    Marrack P; Kappler J
    Immunol Today; 1988 Oct; 9(10):308-15. PubMed ID: 3076400
    [No Abstract]   [Full Text] [Related]  

  • 4. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
    Cheng PC; Steele CR; Gu L; Song W; Pierce SK
    J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes.
    Felix NJ; Donermeyer DL; Horvath S; Walters JJ; Gross ML; Suri A; Allen PM
    Nat Immunol; 2007 Apr; 8(4):388-97. PubMed ID: 17322886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peptidic self model: a hypothesis on the molecular nature of the immunological self.
    Kourilsky P; Claverie JM
    Ann Inst Pasteur Immunol; 1986; 137D(1):3-21. PubMed ID: 3489434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
    Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
    Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell biology of antigen presentation by B cells.
    Pernis B; Weber DA
    Contrib Microbiol Immunol; 1989; 11():27-42. PubMed ID: 2555111
    [No Abstract]   [Full Text] [Related]  

  • 9. Class II MHC/peptide complexes on T cell antigen-presenting cells: agonistic antigen recognition inhibits subsequent antigen presentation.
    Mannie MD; Nardella JP; White GA; Arnold PY; Davidian DK
    Cell Immunol; 1998 Jun; 186(2):111-20. PubMed ID: 9665753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers.
    Lang P; Stolpa JC; Freiberg BA; Crawford F; Kappler J; Kupfer A; Cambier JC
    Science; 2001 Feb; 291(5508):1537-40. PubMed ID: 11222857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
    Brocke P; Armandola E; Garbi N; Hämmerling GJ
    Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How the T cell repertoire becomes peptide and MHC specific.
    Huseby ES; White J; Crawford F; Vass T; Becker D; Pinilla C; Marrack P; Kappler JW
    Cell; 2005 Jul; 122(2):247-60. PubMed ID: 16051149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB; Smith CA; Graham CM
    J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-cell antigen receptor signaling requirements for targeting antigen to the MHC class II presentation pathway.
    Clark MR; Massenburg D; Siemasko K; Hou P; Zhang M
    Curr Opin Immunol; 2004 Jun; 16(3):382-7. PubMed ID: 15134789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous peptides associated with MHC class II and selection of CD4 T cells.
    Rudensky AY
    Semin Immunol; 1995 Dec; 7(6):399-409. PubMed ID: 8775465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of T-cell epitopes.
    Livingstone AM; Fathman CG
    Annu Rev Immunol; 1987; 5():477-501. PubMed ID: 2439104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The density of the class II MHC T cell receptor ligand influences IFN-gamma/IL-4 ratios in immune responses in vivo.
    DiMolfetto L; Neal HA; Wu A; Reilly C; Lo D
    Cell Immunol; 1998 Jan; 183(1):70-9. PubMed ID: 9578721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
    Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
    Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles.
    Pape KA; Catron DM; Itano AA; Jenkins MK
    Immunity; 2007 Apr; 26(4):491-502. PubMed ID: 17379546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.